Skip to main content
Log in

Successful non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) for Waldenström's macroglobulinemia with severe pancytopenia

  • Case Report
  • Published:
Bone Marrow Transplantation Submit manuscript

Abstract

We report a 62-year-old male who underwent non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) because of his life-threatening severe pancytopenia due to refractory Waldenström's macroglobulinemia. This therapy was performed safely and he made a marked recovery from his cytopenia that had not been improved with any other therapy. Bone marrow aspirates showed post-transplant mixed chimerism during engraftment, and became completely donor-derived after a series of GVHD symptoms, without subsequent donor lymphocyte infusion. Our results suggest that non-myeloablative allogeneic PBSCT could be a good alternative for patients suffering from multi-drug resistant Waldenström's macroglobulinemia. Bone Marrow Transplantation (2001) 28, 609–611.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Desikan R, Dhodapkar M, Siegel D et al. High-dose therapy with autologous haemopoietic stem cell support for Waldenström's Macroglobulinemia Br J Haematol 1999 105: 993–996

    Article  CAS  Google Scholar 

  2. Dreger P, Glass B, Kuse R et al. Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenström's macroglobulinaemia Br J Haematol 1999 106: 115–118

    Article  CAS  Google Scholar 

  3. Yang L, Wen BP, Li HM et al. Autologous peripheral blood stem cell transplantation for Waldenström's macroglobulinemia Bone Marrow Transplant 1999 24: 929–930

    Article  CAS  Google Scholar 

  4. Martino R, Shah A, Romero P et al. Allogeneic bone marrow transplantation for advanced Waldenström's macroglobulinemia Bone Marrow Transplant 1999 23: 747–749

    Article  CAS  Google Scholar 

  5. Carella AM, Champlin R, Slavin S et al. Mini-allografts: ongoing trials in humans Bone Marrow Transplant 2000 25: 345–350

    Article  CAS  Google Scholar 

  6. Khouri IF, Keating M, Körbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 1998 16: 2817–2824

    Article  CAS  Google Scholar 

  7. Giralt S, Weber D, Aleman A et al. Non myeloablative conditioning with fludarabine/melphalan (FM) for patients with multiple myeloma (MM) Blood 1999 94: (Suppl. 1) 347a (Abst.1549)

    Google Scholar 

  8. Dimopoulos MA, Panayiotidis P, Moulopoulos LA et al. Waldenström's macroglobulinemia: clinical features, complications, and management J Clin Oncol 2000 18: 214–226

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Masaharu Kouno, Toshitsugu Negoro and Takahiro Yonemoto for their skillful technical assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueda, T., Hatanaka, K., Kosugi, S. et al. Successful non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) for Waldenström's macroglobulinemia with severe pancytopenia. Bone Marrow Transplant 28, 609–611 (2001). https://doi.org/10.1038/sj.bmt.1703190

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703190

  • Springer Nature Limited

Keywords

This article is cited by

Navigation